High-quality pharmacogenomics (PGx) testing is the cornerstone of our success. All samples received by RPRD Diagnostics are processed in our CLIA-certified and fully HIPPA-compliant diagnostic laboratory. RPRD maintains a robust proficiency testing program to ensure the high quality and accurate patient testing. We maintain 100% pass rate on proficiency tests.
RPRD Diagnostics CLIA# 52D2126222
Download the RPRD Diagnostics CLIA Certificate of Compliance
State of California Lab ID: COS 00800867
Download the State of California Clinical Laboratory License
State of Rhode Island State License No: LCO01413
Download the State of Rhode Island Clinical Laboratory License
State of Maryland Medical Laboratory Permit No: 3179
Download the State of Maryland Medical Laboratory Permit
State of Pennsylvania Clinical Laboratory Permit ID No: 38139
Download the State of Pennsylvania Clinical Laboratory Permit
RPRD Diagnostics NPI Number: 1992286074
RPRD is committed to delivering the most accurate test results possible. We’ve built rigorous quality assurance and quality control programs that surpass required diagnostic testing standards.
We continuously review the Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines and scientific literature to ensure our translation and clinical reporting strictly adheres to the most up-to-date clinical practice guidelines and strongest scientific evidence.
RPRD laboratory implements robust policies, procedures and regular auditing to ensure 100% compliance with HIPAA standards. Our information security standards meet or exceed all required implementation specifications.
Assay validation demonstrates >99.9% accuracy/agreement of test results.
Internal quality control system ensures 100% concordance for each run.
Bi-annual comparison of observed allelic frequency and expected frequency based on literature review.